Szemészet, 2002 (139. évfolyam, 1-4. szám)

2002-03-01 / 1. szám

139. évfolyam (2002)

59

9. Kazmer S., Pan K.M, Vassilev L: Quantification of telomerase activity by direct scintillation counting. J Biochem Biophys Methods 12, 113-117 (1999).

10. Kim N.W., Piatyszek M.A., Prowse K.R., Harley C.B., West M.D., Ho P.L.C., Covielo G.M., Wright W.E., Weinrich S.L., Shay J.W.: Specific association of human telomerase activity with immortal cells and cancer. Science 266, 2011-2015 (1994).

11. Lavelle F, Riou J.F., Laoui A., Mailliet P: Telomerase: a therapeutic target for the third millennium. Crit Rev Oncol Hematol 34(2), 111- 126 (2000).

12. Mem S.L.: The role of telomeres in ageing and cancer. Br J Biomed Sei 55(3) 221-225 (1998).

13. Park T.K., Jim K.H.: Telomerase activity in pterygeal and normal conjunctival epithelium. Korean J Ophthalmol 14(2), 85-89 (2000).

14. Rohrbach J.M., Riedinger C„ Wild M„ Partsch M.: Telomeraseaktivität in uvealen Melanomen. Ophthalmologe 97(5), 359-363 (2000).

15. Shay J.W.: Aging and cancer: are telomeres and telomerase the connection? Mol Med Today 1(8), 378-384 (1995).

16. Szatmári I., Tőkés S., Dunn C.B., Bardos T.J., Aradi J.: Modified telomeric repeat amplification protocol: a quantitative radioactive assay for telomerase without using electrophoresis. Anal Biochem 282(1), 80-88 (2000).

17. Szatmári I. Aradi J.: Telomeric repeat amplification, without shortening or lengthening of the telomerase products: a method to analyze the processivity of telomerase enzyme. Nucleic Acids Research 29, e3 (2001).

18. Zhao J.Q., Glasspool R.M., Hoare S.F., Bilsland A., Szatmári I.,

Keith W.N.: Activation of telomerase RNA gene promoter activity by NF-Y, Spl, and the retinoblastoma protein and repression by Sp3. Neoplasia 6, 531-539 (2000).

A szerző levelezési címe: Dr. Kemény-Beke Ádám Debreceni Egyetem, OEC, Szemészeti Kklinika 4012 Debrecen, Nagyerdei krt. 98.

Szemészeti tumorok telomerázaktivitása I.